These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease. Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164 [TBL] [Abstract][Full Text] [Related]
9. A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates. Bamford KA; Caine ED; Kido DK; Cox C; Shoulson I Neurology; 1995 Oct; 45(10):1867-73. PubMed ID: 7477984 [TBL] [Abstract][Full Text] [Related]
10. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease. Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723 [TBL] [Abstract][Full Text] [Related]
11. Structural and functional changes of the visual cortex in early Huntington's disease. Coppen EM; Grond JV; Hafkemeijer A; Barkey Wolf JJH; Roos RAC Hum Brain Mapp; 2018 Dec; 39(12):4776-4786. PubMed ID: 30144208 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of CT in patients with Huntington's chorea and their offspring. Oepen G; Ostertag C J Neurol; 1981; 225(3):189-96. PubMed ID: 6167684 [TBL] [Abstract][Full Text] [Related]
13. Bradykinesia in early Huntington's disease. Sánchez-Pernaute R; Künig G; del Barrio Alba A; de Yébenes JG; Vontobel P; Leenders KL Neurology; 2000 Jan; 54(1):119-25. PubMed ID: 10636136 [TBL] [Abstract][Full Text] [Related]
14. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782 [TBL] [Abstract][Full Text] [Related]
15. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME Arch Neurol; 1992 Nov; 49(11):1161-7. PubMed ID: 1444883 [TBL] [Abstract][Full Text] [Related]
17. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Young AB; Penney JB; Starosta-Rubinstein S; Markel DS; Berent S; Giordani B; Ehrenkaufer R; Jewett D; Hichwa R Ann Neurol; 1986 Sep; 20(3):296-303. PubMed ID: 2945510 [TBL] [Abstract][Full Text] [Related]
18. Cerebellum and brain stem atrophy in a child with Huntington's chorea. Hattori H; Takao T; Ito M; Nakano S; Okuno T; Mikawa H Comput Radiol; 1984; 8(1):53-6. PubMed ID: 6230208 [TBL] [Abstract][Full Text] [Related]
19. Altered patterns of regional cerebral blood flow in patients with Huntington's disease: a SPECT study during rest and cognitive or motor activation. Deckel AW; Weiner R; Szigeti D; Clark V; Vento J J Nucl Med; 2000 May; 41(5):773-80. PubMed ID: 10809191 [TBL] [Abstract][Full Text] [Related]